Sexually Transmitted Infections (STI) Profile, With CT/NG/TV NAA

Casandra

Casandra Test Code LC65001Version 1 (DRAFT)

Performing Lab

Lab LabcorpLab Test ID 144027CPT Codes 87491, 87591, 87661, 86592, 86704, 86706, 86803, 87340, 87389

Sexually Transmitted Infections (STI) Profile, With CT/NG/TV NAA

Also known as: Chlamydia, Gonorrhea, HBV, HCV, Hepatitis

Clinical Use

Order Test

Use

Screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Testing aligns with current guidelines and recommendations.

Special Instructions

Not provided.

Limitations

Some assays in this panel have not been FDA cleared or approved for screening blood or plasma donors and the performance characteristics have not been established for immunocompromised or immunosuppressed patients, cord blood, or patients under 2 years of age.

Test Details

Methodology

PCR-based (qPCR)

Biomarkers

9 components

HBsAg Screen • qPCRHep B Surface Ab, Qual • qPCRHep B Core Ab, Tot • qPCRHCV Ab • qPCR+5 more

LOINC Codes

Order Codes

5196-1 - HBV surface Ag SerPl Ql IA
22322-2 - HBV surface Ab Ser Ql
13952-7 - HBV core Ab SerPl Ql IA
77202-0 - Laboratory comment Report
56850-1 - Imp & review of lab results
13955-0 - HCV Ab SerPl Ql IA
20507-0 - RPR Ser Ql
56888-1 - HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
43304-5 - C trach rRNA Spec Ql NAA+probe
43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe
46154-1 - T vaginalis rRNA Spec Ql NAA+probe
11502-2 - Laboratory report

Result Codes

5196-1 - HBV surface Ag SerPl Ql IA
22322-2 - HBV surface Ab Ser Ql
13952-7 - HBV core Ab SerPl Ql IA
77202-0 - Laboratory comment Report
56850-1 - Imp & review of lab results
13955-0 - HCV Ab SerPl Ql IA
20507-0 - RPR Ser Ql
56888-1 - HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
43304-5 - C trach rRNA Spec Ql NAA+probe
43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe
46154-1 - T vaginalis rRNA Spec Ql NAA+probe

Result Turnaround Time

1-4 days

Specimen

Serum

Volume

8 mL

Minimum Volume

Not provided

Container

gel-barrier tube

Collection Instructions

Usual blood collection technique.

Patient Preparation

Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection.

Causes for Rejection

Hemolysis; lipemia; received outside of specimen and/or storage and/or labeling requirements; aliquot received for HIV testing; specimen in expired transport or incorrect transport device; specimens with inappropriate source for test requested.